Heterociclos com Nitrogénio (N)

Please enquire for more information about 3-Boc-amino-2,6-dioxopiperidine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Sulfamethoxypyridazine is a sulfa drug that inhibits bacterial growth by inhibiting the synthesis of folic acid, which is essential for DNA and RNA production. It has been shown to be effective in the treatment of urinary infections and infectious diseases. Sulfamethoxypyridazine interacts with other drugs, such as oral contraceptives, to increase their blood levels. This drug also has a matrix effect on urine samples, which can be used to detect the presence of bacteria. The matrix effect is due to its hydrophobic nature and ability to form aggregates with other compounds. Sulfamethoxypyridazine is used in wastewater treatment plants as an analytical method for nitrogen atoms.

1-Acetyl-4-(4-hydroxyphenyl)piperazine is a triazole antifungal that inhibits the synthesis and activity of nitric oxide. It binds to the N1 atom of the molecule, which is the site of nitrite ion, and prevents it from reacting with chloride ions. This binding also prevents nucleophilic attack on imine bonds in proteins and DNA. The photophysical properties of 1-acetyl-4-(4-hydroxyphenyl)piperazine are determined by its coumarin derivatives, which absorb light at wavelengths between 400 and 500 nm. The compound has been found to be specific for fungi, but not bacteria or yeast. 1-Acetyl-4-(4-hydroxyphenyl)piperazine has been shown to be effective against Candida albicans and other strains of yeast when used as an oral or topical treatment.

Please enquire for more information about 5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 4,5-Dihydro-1H-imidazol-2-amine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Pyrimidine-carboxylic acid is a biologically active molecule that can be found in the human body. It is a derivative of pyrimidine, which belongs to the group of purines. 2-Pyrimidine-carboxylic acid has been shown to inhibit the nicotinic acetylcholine receptor and α7 nicotinic acetylcholine receptor, which are receptors for acetylcholine. This molecule also has antihypertensive activity and has been shown to have therapeutic effects in psychotic disorders. 2-Pyrimidine-carboxylic acid binds to picolinic acid, which is an important intermediate in the metabolism of tryptophan, and hydroxyl group, which is essential for many biological functions. It also reacts with copper ions and forms a complex that is x-ray crystal structure confirmed. This complex may be used as a herbicide resistance inducer or as a chemical species for receptor binding studies or chemical reactions.

Please enquire for more information about (2E)-1-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)-2-buten-1-one including the price, delivery time and more detailed product information at the technical inquiry form on this page

5-Aminopyridine-3-carboxylic acid (5APC) is a structural analog of nicotinic acid that has been shown to have anti-inflammatory effects. 5APC inhibits the production of inflammatory cytokines, such as IL-10 and IL-17, by inhibiting the activation of NFκB and MAPK pathways. This drug also has significant inhibitory activities against dextran sulfate sodium (DSS)-induced acute colitis in experimental models. 5APC is thought to act by interrupting the assembly of p38 mitogen activated protein kinase (MAPK) and nuclear factor kappa B (NFκB) signaling complexes.

6-Bromo-pyrazolo[1,5-a]pyrimidine is a bone morphogenetic protein (BMP) inhibitor. It has been shown to be a potent inhibitor of the tyrosine kinase activity of BMP receptors and may be useful for the development of new strategies for the treatment of osteoporosis. 6-Bromo-pyrazolo[1,5-a]pyrimidine is also an effective inhibitor of the proliferation and survival of cancer cells. It inhibits cell growth by interfering with cellular signaling pathways that regulate these processes. 6-Bromo-pyrazolo[1,5-a]pyrimidine was also found to inhibit the production of bone morphogenetic protein 2 (BMP2) in mouse calvaria cells without affecting other bone metabolism markers such as alkaline phosphatase or osteocalcin.

2-Amino-6-chloropurine is a nucleophilic substituent that is used in the synthesis of 2-amino-6-chloropurine. It reacts with hydroxyl groups to form a palladium-catalyzed coupling reaction solution, which is then treated with hydrochloric acid and trifluoroacetic acid. The product is purified by crystallization and recrystallization. This compound has potent antitumor activity against carcinoma cell lines, but it has not been shown to have any effect against Mycobacterium tuberculosis.

1,1'-Carbonimidoylbis-1H-imidazole is a ligand that binds to amines and isosteres. It can be activated with electrophilic reagents to form an activated linker. This ligand has been shown to inhibit the growth of xenograft tumor cells in mice by binding to functional groups on the cell surface. This drug also has been shown to bind to the receptor for advanced glycation end products (RAGE) and inhibit its function. 1,1'-Carbonimidoylbis-1H-imidazole has also been evaluated as a cancer therapeutic agent in animal models.

5-Bromo-2-iodopyridine is an antibiotic that is used to treat bacterial infections. It has been shown to inhibit the growth of bacteria by binding to the 50S ribosomal subunit. This drug also has a toxic effect on respiratory system cells, which may be due to its ability to induce apoptosis. 5-Bromo-2-iodopyridine interacts with DNA in a triazine ring and inhibits bacterial growth by inhibiting protein synthesis. The drug binds to the 50S ribosomal subunit at a site that is different from that of rifampin and other antibiotics. The reaction is catalyzed by palladium at high temperatures and takes place in organic solvents such as chloroform or benzene. This synthetic process can be made more efficient by using inexpensive starting materials, such as bromine, iodine, and acetone, rather than expensive starting materials like platinum or gold salts.

2,3,5,6-Tetra-methyl-pyrazine is a chemical compound that is structurally similar to ATP. It has been shown to inhibit the mitochondrial membrane potential and induce apoptosis in rat heart cells. 2,3,5,6-Tetra-methyl-pyrazine has also been shown to inhibit ATP synthase activity and increase lactate levels in the presence of glucose. This compound inhibits cyclase activity and increases microdialysis probe signal pathways. 2,3,5,6-Tetra-methyl-pyrazine may be useful for the treatment of myocardial infarcts.

Please enquire for more information about Coproporphyrin III including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Amino-6-chloropyrimidin-4(3H)-one (ACPP) is a betaine that has been shown to exhibit potent activity against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA). It is a mesomeric molecule, which means that it can exist as two different tautomers. The frequency of the absorption bands in the FTIR spectra for ACPP are characteristic of the carbenes and ethanolamine tautomers. The presence of these tautomers may be due to stabilization from the nucleophilic character of the nitrogen atom in betaines. Betaines are also able to form polymersized chains by reacting with themselves or other molecules, such as ethanolamine.

Please enquire for more information about 2-Chloromethyl-4-(3-methoxypropoxy)-3-methylpyridine hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

2-Bromo-6-methylpyridine-3-carboxaldehyde (BMPCA) is a pharmacological agent that belongs to the group of antagonists. It has been shown to be a potent antagonist at the NMDA receptor and may be used for treating neuropathic pain. BMPCA also has been shown to have competitive inhibition at the naphthyridine receptor, which may allow it to act as an antagonist or an agonist depending on its binding site. The regioisomeric analogs of BMPCA are 2-(2,5-dichloropyridyl)-6-methylpyridine-3-carboxaldehyde and 2-(2,5-dimethylpyridyl)-6-methylpyridine-3-carboxaldehyde. These analogs have been shown to inhibit the growth of tumor cells in vitro and in vivo.

2,4-Dibromopyridine is a brominated derivative of pyridine. It is synthesized through the substitution of two bromine atoms for two hydrogens on the pyridine ring. This synthesis can be achieved by disubstitution or cross-coupling reactions. The reaction products are nucleophilic and react with electrophiles to produce substitution products. The reaction mechanism is thought to involve a six-membered transition state, which has been observed using X-ray absorption spectroscopy.

Please enquire for more information about 8-Chloroimidazo[1,2-a]pyrazine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about 4-Chlorophenyl-2-pyridinylmethanol including the price, delivery time and more detailed product information at the technical inquiry form on this page